CAPTRUST Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.25M Buy
67,522
+5,849
+9% +$628K 0.02% 531
2025
Q1
$6.22M Buy
61,673
+7,093
+13% +$716K 0.02% 536
2024
Q4
$4.88M Buy
54,580
+8,316
+18% +$743K 0.01% 553
2024
Q3
$3.88M Sell
46,264
-5,556
-11% -$466K 0.01% 601
2024
Q2
$3.99M Buy
51,820
+1,332
+3% +$103K 0.01% 564
2024
Q1
$3.46M Sell
50,488
-34,875
-41% -$2.39M 0.01% 603
2023
Q4
$4.93M Buy
85,363
+10,167
+14% +$588K 0.02% 565
2023
Q3
$3.97M Buy
75,196
+21,158
+39% +$1.12M 0.02% 601
2023
Q2
$2.92M Buy
54,038
+273
+0.5% +$14.8K 0.01% 692
2023
Q1
$2.69M Buy
53,765
+6,298
+13% +$315K 0.01% 647
2022
Q4
$2.2M Buy
47,467
+10,064
+27% +$466K 0.01% 689
2022
Q3
$1.45M Buy
37,403
+3,948
+12% +$153K 0.01% 778
2022
Q2
$1.25M Buy
33,455
+5,926
+22% +$221K 0.01% 747
2022
Q1
$1.22M Buy
27,529
+2,801
+11% +$124K 0.01% 768
2021
Q4
$1.05M Sell
24,728
-151
-0.6% -$6.41K 0.01% 794
2021
Q3
$1.08M Buy
24,879
+2,527
+11% +$110K 0.01% 721
2021
Q2
$956K Sell
22,352
-1,573
-7% -$67.3K 0.01% 734
2021
Q1
$925K Buy
23,925
+10,110
+73% +$391K 0.01% 721
2020
Q4
$497K Sell
13,815
-1,426
-9% -$51.3K 0.01% 833
2020
Q3
$586K Buy
15,241
+3,478
+30% +$134K 0.01% 670
2020
Q2
$415K Buy
11,763
+1,965
+20% +$69.3K 0.01% 772
2020
Q1
$296K Sell
9,798
-3,113
-24% -$94K 0.01% 728
2019
Q4
$585K Buy
12,911
+3,708
+40% +$168K 0.01% 635
2019
Q3
$374K Buy
9,203
+511
+6% +$20.8K 0.01% 456
2019
Q2
$374K Sell
8,692
-844
-9% -$36.3K 0.01% 445
2019
Q1
$366K Buy
9,536
+265
+3% +$10.2K 0.01% 402
2018
Q4
$328K Buy
9,271
+41
+0.4% +$1.45K 0.02% 356
2018
Q3
$355K Buy
9,230
+6,101
+195% +$235K 0.02% 351
2018
Q2
$102K Buy
3,129
+1,594
+104% +$52K 0.01% 505
2018
Q1
$41K Sell
1,535
-1,215
-44% -$32.5K ﹤0.01% 654
2017
Q4
$68K Buy
+2,750
New +$68K ﹤0.01% 522